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EDITORIAL
Since their introduction into clinical medicine more than 60
years ago, antibiotics have become the main means of control-
ling bacterial infection. However, the emergence of micro-
organisms that are resistant to antimicrobial agents has in-
creased and continues to increase at an alarming rate, making
the effective control of infectious diseases a major challenge to
public health. The emergence of resistance to antibiotics is no
more than an unavoidable and perhaps irreversible conse-
quence of bacterial adaptation to the selective pressure of
antibiotics. The unlimited and indiscriminate use of antibiotics
over long periods of time in biological systems, such as hu-
mans, other animals, and/or plants, has allowed and even pro-
moted the emergence and spread of resistance to antibiotics.
Antimicrobial agents have been found in sewage, and they
later contaminate rivers, lakes, and oceans. This interconnec-
tion between ecosystems promotes a strong selective pressure,
altering the environment and advancing the emergence and
spread of resistant microorganisms. 
β-Lactams are the most varied and widely used of all the
groups of antimicrobial agents in human and veterinary med-
icine. They act by inhibiting the final phase of bacterial cell-
wall synthesis. These drugs have little toxicity and a broad
therapeutic margin. Penicillins and cephalosporins, which are
based on 6-aminopenicillanic acid and 7-aminocephalospo-
ranic acid, respectively, are the two classical β-lactam fami-
lies. Moreover, β-lactams such as monobactams and car-
bapenems have also been developed. Although β-lactams are
the treatment of choice for a large number of infections, the
progressive emergence of acquired resistance has limited
their use and their efficacy in certain situations. 
Bacteria may become resistant through several mecha-
nisms: production of enzymes that inactivate an antibiotic,
alteration of the target (the bacterial molecule with which the
antimicrobial agent interacts), alteration of permeability, and
activation of trans-membrane efflux (active pumping out).
Mutations of cellular genes, acquisition of exogenous resist-
ance genes, or a combination of these two events are respon-
sible for these mechanisms. A good example of acquired
resistance due to point mutations is provided by the acquired
resistance to nearly all cephalosporins and monobactams in
some gram-negative bacteria due to the derepression of a
chromosomal cephalosporinase encoded by the β-lactam-
inducible ampC gene. Organisms such as Enterobacter spp.,
Citrobacter freundii, Serratia marcescens, Morganella
morganii, and Pseudomonas aeruginosa express low levels
of an AmpC β-lactamase; however, the enzyme is induced in
response to β-lactams (e.g., cefoxitin or imipenem). AmpC
β-lactamases are active-site serine enzymes that are primarily
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cephalosporinases. Induction of ampC expression appears to
involve several gene products associated with this pathway,
including AmpR, AmpD, and AmpG. Organisms expressing
these enzymes are not resistant to third-generation cepha-
losporins unless the AmpC β-lactamase is expressed at high
levels. Point mutations in one or some of these regulatory
genes alter the expression of AmpC β-lactamase and may
promote the above-mentioned resistance pattern. Other
examples are the acquisition of resistance to carbapenems
due to point mutations that alter the permeability by altering
the expression of certain porins, such as OprD of P. aerugi-
nosa, or to the presence of mutant bacteria that over-express
efflux pump genes. Efflux systems that contribute to antibi-
otic resistance have been described in a number of clinically
important bacteria, including P. aeruginosa, Campylobacter
jejuni, Escherichia coli, Streptococcus pneumoniae, Salmo-
nella enterica, and Staphylococcus aureus. 
There are many examples in the literature of gene acqui-
sition. One of the most evident examples is the acquisition of
degrading enzymes, such as aminoglycoside-modifying
enzymes or β-lactamases. Another example is the acquisition
of new targets that are resistant to antimicrobial action, such
as the mecA gene by S. aureus. This acquired gene confers
resistance to all β-lactam antibiotics by the production of a
new penicillin-binding protein, PBP2′ (PBP: transpeptidase,
transglycosylase, and carboxypeptidase enzymes that manu-
facture the peptidoglycan of the bacteria). S. aureus carrying
PBP2′ are named methicillin-resistant S. aureus (MRSA),
and they are clinically relevant microorganisms due to their
pathogenic end epidemic features.
Finally, acquisition of a resistance gene and its evolution
by mutation is frequently observed among Enterobac-
teriaceae and β-lactamases. The wild-type E. coli strain is
susceptible to aminopenicillins, cephalosporins, and the asso-
ciation amoxicillin–clavulanic acid (an inhibitor of β-lacta-
mases). However, about 60% of E. coli strains are nowadays
resistant to aminopenicillins due to production of plasmid-
mediated β-lactamases, such as TEM-1, TEM-2, and SHV-1,
known as broad-spectrum β-lactamases. Although these
strains remain susceptible to cephalosporins and amoxi-
cillin–clavulanic acid, the acquired genes can mutate and a
single nucleotide alteration (mainly in amino acid 238) can
spread resistance to aminopenicillins and cephalosporins.
These newly derived enzymes are called extended-spectrum
β-lactamases (ESBL) due to their increased spectrum of acti-
vity. Mutations of the broad-spectrum TEM-type enzymes
(mainly in amino acid 69) can also confer resistance to β-lac-
tamase inhibitors, such as clavulanic acid, but not to cepha-
losporins. These enzymes are named inhibitor resistant β-lac-
tamases. 
The above-mentioned genes can spread rapidly within a
bacterial population and from one environment to another by
sharing and exchanging genetic information. Resistance
between bacteria may be transferred by several mechanisms.
When the selective pressure of antibiotics is exerted, bacteria
already have a large population of resistance genes available
to them. This provides an environment where the development
and spread of antibiotic resistance is likely to continue indefi-
nitely, both due to the selective pressure of antibiotics and to
resistance already present in the population. 
The principal mechanisms by which transfer and uptake
of resistance can occur are transformation, transduction, and
conjugation. Bacteria can pick up naked DNA from their envi-
ronment through the process of transformation. The DNA
may come from a variety of sources, but the most frequent is
remnants from dead bacterial cells. In transformation, a cell-
surface receptor binds to DNA, which is then transported
across the membrane and one strand of the DNA is digested
away. The DNA that enters the cell is thus single-stranded. As
long as the incorporated DNA is sufficiently homologous to
the host DNA, recombination occurs and the new DNA will
replace a strand of the host DNA. If the new DNA is of a dif-
ferent allelic nature than the host DNA, a gene conversion
event can occur. 
β-Lactams resistance in S. pneumoniae (gene pbp2X, pbp2B,
and pbp1A), Helicobacter pylori (gene pbp1A) or neisseria-
ceae (gene penA) due to subsequent recombinations of differ-
ent DNA fragments are examples of acquisition of resistance
by transformation and recombination. These DNA fragments
confer a gene mosaic pattern to their PBPs, resulting in a low
affinity for β-lactam antibiotics. Similarly, there are some
examples for other non-β-lactam drugs, such as quinolones
in S. pneumoniae (mosaic patterns of gyrA and parC genes),
tetracycline in Gardnerella vaginalis, Mycoplasma hominis,
or Ureaplasma urealyticum (gene tetM), and the resistance to
sulfamides and trimethoprim in general (sul and dfr).
Bacteriophages provide one of the most efficient vehicles
for moving DNA sequences between bacterial cells. One con-
sequence of transduction is the dissemination of sequences
allowing bacteria to become more pathogenic and antibiotic
resistant. Diffusion of resistance by transduction was first
documented by the diffusion of the enzyme penicillinase
within S. aureus. Although the gene that codifies this penicil-
linase is present within a plasmid, the plasmid is small enough
to be packaged entirely within a viral particle, which explains
its rapid diffusion among S. aureus strains. This resistance is
now present in about 95% of all clinically relevant S. aureus
strains, as well as in other Staphylococcus species. Moreover,
the occurrence of phage particles carrying sequences of blaOXA-
and blaPSE -related genes that encode β-lactamases has recent-
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ly been demonstrated in sewage. The potential contribution of
phages to the spread of some β-lactamase genes therefore
seems quite likely.
Conjugation, first discovered in 1946 by Lederberg and
Tatum, is another method that is very adaptable and efficient
for intra- or inter-species genetic transfer. This process in-
volves direct cell-to-cell contact of two bacterial cells and the
subsequent transfer of DNA. Conjugation can occur between
species that are unrelated; for this reason, a large gene pool is
available with which bacteria can exchange and acquire new
genetic material. Sex pili make contact between the donor
and the recipient cell in gram-negative bacteria. Once the two
cell walls are in contact, a mating bridge is formed. The plas-
mid DNA in the donor, which may contain antibiotic resist-
ance genes, is nicked in one strand; this strand proceeds into
the recipient cell by undergoing rolling-circle replication.
Complementary copies of the DNA are produced in both the
donor and the recipient cells. Finally, the linear plasmid in
the recipient becomes circular and both cells then have a
copy of the plasmid. 
Since their discovery in the late 1950s, antimicrobial
resistance in both gram-negative and gram-positive bacteria
have been increasingly associated with plasmids. It has been
documented that many of the β-lactamase genes detected
within plasmids have a chromosomal origin. Some examples
are the chromosomal AmpC β-lactamases present in the
above-mentioned species that are now found in plasmids.
Similarly, some ESBL originate from chromosomal enzy-
mes, such as SHV-1 of Klebsiella pneumoniae or the CTX-M
enzymes derived from different species of Kluyvera.
Nowadays, plasmid-mediated diffusion of β-lactamases is of
great concern and contributes to the enormous diffusion of
this kind of enzyme throughout the microbial world. About
60% of E. coli strains are now considered to carry a TEM-1,
TEM-2, or SHV-1 enzyme. Broad-spectrum β-lactamase de-
rivatives and other ESBL that appeared in the mid-1980s are
increasing among E. coli strains (and other species). These
enzymes drastically reduce the therapeutic options to treat
infections. The reservoir of such enzymes might be the com-
mensal microbiota of healthy individuals and not only
patients undergoing antibiotic treatment. 
Gene-transfer mechanisms provide a starting point for
other, more complex mechanisms of development and spread
of resistance, such as mobile genetic elements (other than the
previously mentioned bacteriophages and plasmids). These
elements allow mobilization of specific DNA fragments from
one region to another, from plasmids to plasmids, from chro-
mosome to chromosome, and between plasmids and chromo-
somes. The most relevant transposable elements are insertion
sequences, transposons, and gene cassettes of integrons.
Insertion sequences and transposons are similar structures
that differ in size and gene content. Insertion sequences are
small elements that encode only their capacity for replicative
recombination, whereas transposons are larger, apparently
composite elements terminated by insertion sequences and
containing genes within the central region (frequently antimi-
crobial resistance genes). Transposable elements cannot exist
as free particles in a bacterium. They are integrated in the
bacterial genome or in the genetic material of a plasmid or a
prophage. They have the ability to move between these sites
using an enzyme called transposase. 
The participation of transposable elements in the diffu-
sion of β-lactamases has been widely observed, with the
CTX-M family of ESBL being the most frequently studied.
As mentioned above, most CTX-M enzymes seem to origi-
nate from the chromosomal genes of different Kluyvera
species and have been described within conjugative plas-
mids. Moreover, many of these genes have been associated
with insertion sequences or transposons, such as IS10, IS26,
ISEcp1, and IS903-like and Tn21-related transposons.
The other elements that have been also associated with β-
lactamases are integrons. Integrons are defined as elements
containing the genetic determinants of the components of a
site-specific recombination system that recognizes and cap-
tures mobile gene cassettes. These gene cassettes could be
resistance genes and frequently are genes that codify for β-lac-
tamases. An integron includes both a gene encoding an inte-
grase and an integration site for the gene cassette. Finally,
following the earlier identification of bacterial conjugation,
research has revealed numerous combinations of genetic
modules derived from bacteriophages, plasmids, and trans-
posons. These modules generate conjugative and mobilizable
transposons as well as genomic islands.
In conclusion, gene transfer is a widespread phenomenon
that may occur in a variety of ways. A good example is the
acquisition and diffusion of β-lactam resistance, an event that
drastically limits treatment options. Even if selective pres-
sure by antibiotics were reduced, resistance could still spread
through the population in ways such as those described
above. A wide, multidisciplinary approach is therefore needed
to control the spread of resistance genes not only in bacteria,
but also among fungi, viruses, and parasites. 
β-LACTAM RESISTENCE
